O'Dea, et al. v. Reckitt Benckiser, LLC — 9th Cir. (argued September 2, 2026)
The Ninth Circuit hears two consolidated appeals over acne treatments that consumers say formed benzene as their benzoyl peroxide degraded. The district court dismissed their suits as preempted by federal drug law. Preemption asks whether federal law displaces state-law claims. The consumers say their claims parallel federal manufacturing requirements; the manufacturers say no binding two-parts-per-million limit applies and federal law reserves enforcement to the FDA. Trenton Kashima will represent the consumers. He will ask the court to revive their claims.
O'Dea, et al. v. Reckitt Benckiser, LLC (No. 25-3240 / 25-3271) — U.S. Court of Appeals for the Ninth Circuit, argued September 2, 2026.
- 0:00Introduction
- 25:26David M. Zionts — Defendants
- 32:49Res ipsa loquitur